NCT01229644 2018-07-05Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult GliomasArog Pharmaceuticals, Inc.Phase 2 Terminated10 enrolled
NCT01393912 2017-04-26PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade GliomaSt. Jude Children's Research HospitalPhase 1 Completed55 enrolled